These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32140288)
1. The Challenge of Diagnosing SAVI: Case Studies. Cao Y; Jiang LP Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):167-172. PubMed ID: 32140288 [No Abstract] [Full Text] [Related]
2. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China]. Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827 [No Abstract] [Full Text] [Related]
3. Use of Tofacitinib for infant-onset STING-associated vasculopathy: A case report from China. Shen D; Fan X; Zhou Q; Xu X; Lu M Medicine (Baltimore); 2022 Dec; 101(48):e31832. PubMed ID: 36482559 [TBL] [Abstract][Full Text] [Related]
5. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports. Dai Y; Liu X; Zhao Z; He J; Yin Q Front Pediatr; 2020; 8():577918. PubMed ID: 33425809 [No Abstract] [Full Text] [Related]
6. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023 [TBL] [Abstract][Full Text] [Related]
7. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review. Wang Y; Wang F; Zhang X Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478 [TBL] [Abstract][Full Text] [Related]
8. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions. Latour-Álvarez I; Murcia-Clemente L; Vázquez Pigueiras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A Pediatr Dermatol; 2024; 41(5):893-896. PubMed ID: 38682895 [TBL] [Abstract][Full Text] [Related]
9. The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation. Shindo R; Kuchitsu Y; Mukai K; Taguchi T Front Cell Dev Biol; 2022; 10():1037999. PubMed ID: 36438571 [TBL] [Abstract][Full Text] [Related]
10. Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey. Balci S; Ekinci RMK; de Jesus AA; Goldbach-Mansky R; Yilmaz M Clin Immunol; 2020 Mar; 212():108273. PubMed ID: 31626957 [TBL] [Abstract][Full Text] [Related]
11. Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome. Berrada KR; Belot A; Neven B; Ohlmann C; Tronc F; Rice G; Thouvenin G; Dubus JC; Mazenq J; Frémond ML; Stremler N; Soummer-Feuillet S; Cottin V; Reix P J Clin Immunol; 2023 Nov; 43(8):2156-2164. PubMed ID: 37814086 [TBL] [Abstract][Full Text] [Related]
12. A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant. Barry KK; Kranseler JS; Robinson SN Pediatr Dermatol; 2024; 41(4):697-700. PubMed ID: 38369300 [TBL] [Abstract][Full Text] [Related]
13. STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib. Tang X; Xu H; Zhou C; Peng Y; Liu H; Liu J; Li H; Yang H; Zhao S J Clin Immunol; 2020 Jan; 40(1):114-122. PubMed ID: 31705453 [TBL] [Abstract][Full Text] [Related]
14. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report. Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067 [TBL] [Abstract][Full Text] [Related]
15. Familial Interstitial Lung Disease Caused by Mutation of the Li J; An S; Du Z Front Pediatr; 2020; 8():543. PubMed ID: 33014937 [TBL] [Abstract][Full Text] [Related]
16. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. Wu J; Zhou Q; Zhou H; Lu M Pediatr Rheumatol Online J; 2023 Oct; 21(1):131. PubMed ID: 37884945 [TBL] [Abstract][Full Text] [Related]
17. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling. Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229 [TBL] [Abstract][Full Text] [Related]